UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 216

Sortiert nach

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study

Journal of psychiatric research, 2019-04, Vol.111, p.59-67

2019

Link zum Volltext

Verfügbarkeit prüfen

Resting-state functional connectivity, cortical GABA, and neuroactive steroids in peripartum and peripartum depressed women: a functional magnetic resonance imaging and spectroscopy study

Neuropsychopharmacology (New York, N.Y.), 2019-02, Vol.44 (3), p.546-554

2019

Link zum Volltext

Verfügbarkeit prüfen

Maintenance treatment of psychotic depression: Is antipsychotic medication needed?

Acta psychiatrica Scandinavica, 2024-01, Vol.149 (1), p.3-5

Rothschild, Anthony J.

2024

Link zum Volltext

Verfügbarkeit prüfen

Can Psychopharmacology Do More for Our Patients With Anosognosia?

Journal of clinical psychopharmacology, 2023-05, Vol.43 (3), p.197

Rothschild, Anthony J

2023

Link zum Volltext

Verfügbarkeit prüfen

Should Antipsychotic Medications Be Prescribed to Patients With Nonpsychotic Depression?

Journal of clinical psychopharmacology, 2022-05, Vol.42 (3), p.231

Rothschild, Anthony J

2022

Link zum Volltext

Verfügbarkeit prüfen

Pharmacotherapy Prescriptions for Relapse Prevention of Psychotic Depression After Electroconvulsive Therapy

Journal of clinical psychopharmacology, 2021-03, Vol.41 (2), p.196

2021

Link zum Volltext

Verfügbarkeit prüfen

Challenges in the treatment of major depressive disorder with psychotic features

Schizophrenia bulletin, 2013-07, Vol.39 (4), p.787-796

Rothschild, Anthony J

2013

Link zum Volltext

Verfügbarkeit prüfen

Genomic Investigation of Remission and Relapse of Psychotic Depression Treated with Sertraline plus Olanzapine: The STOP-PD II Study

Neuropsychobiology, 2023-06, Vol.82 (3), p.168

2023

Link zum Volltext

Verfügbarkeit prüfen

Why Is There No Food and Drug Administration-Approved Medication for Major Depression With Psychotic Features?

Journal of clinical psychopharmacology, 2021-07, Vol.41 (4), p.359

Rothschild, Anthony J

2021

Link zum Volltext

Verfügbarkeit prüfen

Psychopharmacology: Back to Basics

Journal of clinical psychopharmacology, 2022-01, Vol.42 (1), p.1

Rothschild, Anthony J

2022

Link zum Volltext

Verfügbarkeit prüfen

Journal of Clinical Psychopharmacology Updates

Journal of clinical psychopharmacology, 2021-11, Vol.41 (6), p.622

Rothschild, Anthony J

2021

Link zum Volltext

Verfügbarkeit prüfen

Thank You and Welcome

Journal of clinical psychopharmacology, 2021-03, Vol.41 (2), p.95

Rothschild, Anthony J

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparing sensitivity to change using the 6-item versus the 17-item Hamilton depression rating scale in the GUIDED randomized controlled trial

BMC psychiatry, 2019-12, Vol.19 (1), p.420-10, Article 420

2019

Link zum Volltext

Verfügbarkeit prüfen

Does Psychosis Increase the Risk of Suicide in Patients with Major Depression? A Systematic Review

Journal of affective disorders, 2016-07, Vol.198, p.23-31

2016

Link zum Volltext

Verfügbarkeit prüfen

Trial of SAGE-217 in Patients with Major Depressive Disorder

The New England journal of medicine, 2019-09, Vol.381 (10), p.903-911

2019

Link zum Volltext

Verfügbarkeit prüfen

Improvement in Depression is Associated with Improvement in Cognition in Late-Life Psychotic Depression

The American journal of geriatric psychiatry, 2017-06, Vol.25 (6), p.672-679

2017

Link zum Volltext

Verfügbarkeit prüfen

Demonstration of the Efficacy and Safety of a Novel Substance P (NK ) Receptor Antagonist in Major Depression

Neuropsychopharmacology (New York, N.Y.), 2004-02, Vol.29 (2), p.385-392

2004

Link zum Volltext

Verfügbarkeit prüfen

Changes in Depression Subtypes Among Men in STARD: A Latent Transition Analysis

American journal of men's health, 2018-01, Vol.12 (1), p.5-13

2018

Link zum Volltext

Verfügbarkeit prüfen

Relationship Between Cerebrovascular Risk, Cognition, and Treatment Outcome in Late-Life Psychotic Depression

The American journal of geriatric psychiatry, 2015-12, Vol.23 (12), p.1270-1275

2015

Link zum Volltext

Verfügbarkeit prüfen

Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial

JAMA psychiatry (Chicago, Ill.), 2020-07, Vol.77 (7), p.674

2020

Link zum Volltext

Verfügbarkeit prüfen

Effects of Preexisting Psychotropic Medication Use on a Cohort of Patients with Ischemic Stroke Outcome

Stroke research and treatment, 2020-09, Vol.2020, p.9070486-8

2020

Link zum Volltext

Verfügbarkeit prüfen

Direct-to-Consumer Advertising Survey of Psychiatrists in Massachusetts and Michigan

Journal of clinical psychopharmacology, 2024-01, Vol.44 (1), p.5

2024

Link zum Volltext

Verfügbarkeit prüfen

Effect of Sertraline on Risk of Falling in Older Adults with Psychotic Depression on Olanzapine: Results of a Randomized Placebo-Controlled Trial

The American journal of geriatric psychiatry, 2014-04, Vol.22 (4), p.332-336

2014

Link zum Volltext

Verfügbarkeit prüfen

Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder

Journal of psychiatric research, 2011-01, Vol.45 (1), p.96-103

2011

Link zum Volltext

Verfügbarkeit prüfen

Vitamin D supplementation in bipolar depression: A double blind placebo controlled trial

Journal of psychiatric research, 2017-12, Vol.95, p.48-53

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 216

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(170)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(161)
Life Sciences & Biomedicine
(156)
Humans
(149)
Psychiatry
(134)
Female
(97)
Male
(87)
Adult
(86)
Middle Aged
(71)
Biological And Medical Sciences
(66)
Medical Sciences
(65)
Depression
(56)
Psychology. Psychoanalysis. Psychiatry
(55)
Aged
(44)
Psychopathology. Psychiatry
(43)
Depressive Disorder, Major - Drug Therapy
(41)
Neurosciences & Neurology
(39)
Treatment Outcome
(39)
Mental Depression
(33)
Adult And Adolescent Clinical Studies
(31)
Double-Blind Method
(31)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study

Resting-state functional connectivity, cortical GABA, and neuroactive steroids in peripartum and peripartum depressed women: a functional magnetic resonance imaging and spectroscopy study

Maintenance treatment of psychotic depression: Is antipsychotic medication needed?

Can Psychopharmacology Do More for Our Patients With Anosognosia?

Should Antipsychotic Medications Be Prescribed to Patients With Nonpsychotic Depression?

Pharmacotherapy Prescriptions for Relapse Prevention of Psychotic Depression After Electroconvulsive Therapy

Challenges in the treatment of major depressive disorder with psychotic features

Genomic Investigation of Remission and Relapse of Psychotic Depression Treated with Sertraline plus Olanzapine: The STOP-PD II Study

Why Is There No Food and Drug Administration-Approved Medication for Major Depression With Psychotic Features?

Psychopharmacology: Back to Basics

Journal of Clinical Psychopharmacology Updates

Thank You and Welcome

Comparing sensitivity to change using the 6-item versus the 17-item Hamilton depression rating scale in the GUIDED randomized controlled trial

Does Psychosis Increase the Risk of Suicide in Patients with Major Depression? A Systematic Review

Trial of SAGE-217 in Patients with Major Depressive Disorder

Improvement in Depression is Associated with Improvement in Cognition in Late-Life Psychotic Depression

Demonstration of the Efficacy and Safety of a Novel Substance P (NK ) Receptor Antagonist in Major Depression

Changes in Depression Subtypes Among Men in STARD: A Latent Transition Analysis

Relationship Between Cerebrovascular Risk, Cognition, and Treatment Outcome in Late-Life Psychotic Depression

Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial

Effects of Preexisting Psychotropic Medication Use on a Cohort of Patients with Ischemic Stroke Outcome

Direct-to-Consumer Advertising Survey of Psychiatrists in Massachusetts and Michigan

Effect of Sertraline on Risk of Falling in Older Adults with Psychotic Depression on Olanzapine: Results of a Randomized Placebo-Controlled Trial

Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder

Vitamin D supplementation in bipolar depression: A double blind placebo controlled trial

Suchergebnisse filtern